AJM MED-i-CAPS Ltd: Biotechnology & medicine

Jun 19 • 25 SEMIFINALISTS • 520 Views • No Comments on AJM MED-i-CAPS Ltd: Biotechnology & medicine

AJM Med-i-caps delivers a low-cost and highly accurate solution for early-stage bowel cancer detection. An electronic capsule is combined with injectable nanoparticles that highlight early-stage cancers, thus making cancer screening easy, painless and accurate.  AJM Med-i-caps offers a platform technology based on cutting edge research.

The Problem: 

Bowel cancer screening has yet to become appealing for everyone that is at risk from this disease.  The biggest problem of bowel cancer is that patients are deterred by the current screening methods that results to less frequent tests. In addition to that current tests do not provide the required accuracy.  

AJM Med-i-caps’s Solution:

Bowel cancer is a preventable disease if only it can be diagnosed early. AJM med-i-caps introduces an easy and painless method for bowel screening using a fluorometric capsule. This ingestible capsule is combined with fluorescent diagnostics that label early stages of cancer. The capsule travels through the bowel the capsule detecting any highlighted lesion accurately. The test can be used routinely by groups at high risk to develop colorectal cancer.


Contact details

Julio Georgiou,  Founder & CEO

Email: julio@ucy.ac.cy

Website: www.ajmmedicaps.com


Related Posts

Comments are closed.

« »